Oxonica Limited is an advanced materials business which licences patents related to nanomaterials. Such agreements exist with Croda Europe Ltd in the UK and BD (formerly Becton Dickinson) in the USA.

The Group is headquartered in Haddenham, Buckinghamshire, United Kingdom.

Latest news

» More news articles

Reports & accounts

Annual Report and Accounts 2017


Annual Report and Accounts 2016


Annual Report and Accounts 2015


» All reports & accounts

About Oxonica

Since January 2010, the Company has focused on rebuilding its financial resources to ensure its ability to continue trading for the foreseeable future and to support return of capital payments to shareholders.

In July 2010, the Company sold Oxonica Materials Inc. to Cabot Corporation, generating nett proceeds of approximately US$4 million. Since that time, return of capital payments have been made to shareholders at the level of 1.9p per share, paid in two tranches.

The Company now has sufficient cash resources to sustain operations in order to benefit from a licence agreement with Croda Europe Ltd. and to see the potential benefits of a licence agreement with BD (formerly Becton, Dickinson) in the USA.

Note to shareholders: Should you have any questions relating to your shareholdings in Oxonica, including the replacement or issuance of share certificates, please email the Company Secretary, Steven Parker, at steven.parker@oxonica.com or write to him at Oxonica Ltd., PO Box 1069, Aylesbury, HP22 9PH, UK.

» Find out more about Oxonica Ltd.